Results (3628)
EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its May 2024 meeting
Ixchiq was assessed under the OPEN framework to promote global public health
Durveqtix received support through the PRIority Medicines (PRIME) scheme due to its potential to improve patients’ quality of life
EMA publishes 2023 annual report
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
Question-and-answer document clarifies regulatory requirements for devices used in combination with medicines
EMA launches fifth communication perception survey
The European Medicines Regulatory Network (EMRN) has been designated as WHO Listed Authority (WLA) by the World Health Organization (WHO).
Review of studies raises possible safety concern and finds no effect in preventing premature birth